Recurrent pneumonia among Japanese adults: disease burden and risk factors

Abstract

BackgroundIn Japan and other societies with rapidly aging populations, recurrent pneumonia (RP) is a major clinical problem yet only limited information exists regarding the burden of this disease.MethodsA prospective study of adult pneumonia was conducted to investigate the incidence of RP and potential risk factors. From February 1, 2012 to January 31, 2013, patients aged ≥ 15 years who were diagnosed with pneumonia were prospectively enrolled in a representative community hospital located in central Japan. Patients were followed for one-year to evaluate the recurrence of pneumonia and characteristics associated with RP. Cox proportional hazards models were constructed to compute adjusted hazard ratios (aHR) and ascertain risk factors significantly associated with RP.ResultsIn total, 841 patients with a median age of 73 years (range 15–101 years) were enrolled totaling 1,048 person-years of observation with a median follow-up time of 475 days. A total of 137 patients had at least one recurrent episode with an incidence rate of 13.1 per 100 person-years (95% confidence interval: 11.1–15.5). In multivariate analysis, a past history of pneumonia (aHR 1.95, 95% CI: 1.35–2.8), chronic pulmonary disease (aHR 1.86, 1.24–2.78) and inhaled corticosteroid usage (aHR 1.78, 1.12–2.84) and hypnotic/sedative medication usage (aHR 2.06, 1.28–3.31) were identified as independent risk factors for recurrent pneumonia, whereas angiotensin converting enzyme-inhibitors usage was associated with a reduction of the risk of RP (aHR 0.22, 0.05–0.91). The detection of P. aeruginosa was significantly associated with RP even after adjusting for chronic pulmonary diseases (aHR = 2.37).ConclusionsRecurrent pneumonia constitutes a considerable proportion of the pneumonia burden in Japan. A past history of pneumonia, chronic pulmonary disease, inhaled corticosteroid and hypnotic/sedative medication usage and detection of P. aeruginosa were identified as independent risk factors for recurrent pneumonia and special attention regarding the use of medications in this vulnerable population is needed to reduce the impact of this disease in aging populations.Electronic supplementary materialThe online version of this article (doi:10.1186/s12890-016-0359-1) contains supplementary material, which is available to authorized users.

Risk factors analysis of nosocomial pneumonia in elderly patients with acute cerebral infraction

“…This strong association with a past history of pneumonia indicates that pneumonia is a reflection of a frail condition and the aggregate of many risk factors of contracting pneumonia. [31] Patients with a previous history of pneumonia were at a higher risk of CAP in the current study, especially those whose initial episode occurred more than 2 years previously; in previous studies, the risk was higher for more recent episodes. [32] In addition, elderly patients with recent episodes of pneumonia are less likely to recognize the symptoms and the seriousness of the illness, and therefore less likely to seek early treatment, averting hospital admission.…”

Effect of tobacco smoking on the risk of developing community acquired pneumonia: A systematic review and meta-analysis

“…This review provides good evidence to support recommendations for smoking cessation as well as avoidance of passive exposure to tobacco smoke, particularly in persons at high risk of developing pneumonia. Patients who recover from an episode of CAP are recognised to be at risk of recurrent CAP[62–64]. Therefore hospitalisation with CAP provides a valuable ‘teachable moment’ when smoking cessation should be promoted.…”

Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged ≥65 years in Japan

“…This single-center prospective study was conducted at Kameda Medical Center (KMC), Kamogawa, Chiba, Japan, as part of the Adult Pneumonia Study Group-Japan (APSG-J) Study [2,[11][12][13]. The APSG-J Study was a multicenter prospective study of adult pneumonia conducted at four community-based hospitals in Japan from September 2011 to August 2014.…”